Sit Less, Interact and Move More (SLIMM) 2 Study | MicrobiomeTrials← Back to trialsNCT05173714
Sit Less, Interact and Move More (SLIMM) 2 Study
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-12-01Est. Completion: 2026-12-31
Enrollment target: 156 participants Locations- Stanford University, Stanford, California, United States
- University of Utah, Salt Lake City, Utah, United States
Other microbiome trials you might be interested in
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic MalignanciesDysmyelopoietic SyndromesHematopoetic MyelodysplasiaMyeloid Leukemia, AcuteNonlymphoblastic Leukemia, AcuteLeukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
ENROLLING_BY_INVITATION
Chronic Kidney Disease (CKD)Health CommunicationPatient Comprehension
For adults ≥65 years and their providers, the investigators will test the usability and design of a tool to replace stan…
Los Angeles, United StatesCompleted Feb 2, 2027
Atherosclerotic Cardiovascular DiseaseOverweightObesity
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as …
Daphne, United StatesEst. completion Jun 30, 2028